Von Willebrand factor antigen in systemic lupus erythematosus and antiphospholipid syndrome
To study clinical significance of von Willebrand factor antigen (WFA) in antiphospholipid syndrome and systemic lupus erythematosus (SLE). Material and methods. Serum concentration of WFA was determined with immune-enzyme assay in 21 pts with primary APS (PAPS), 39 SLE pts with APS, 68 SLE pts and 5...
Saved in:
| Main Authors: | A A Novikov, E N Alexandrova, T V Popkova, T M Reshetnyak, N G Klyukvina, D S Novikova, LB Slitivelband, A A Baranov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2004-08-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/936 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factor fon Willebrand antigen in endothelium functional state assessment in patients with systemic lupus erythematosus
by: M E Zapryagaeva, et al.
Published: (2004-06-01) -
von Willebrand Factor (VWF) Inhibitors in Two Brothers with von Willebrand Disease: A Case Report
by: Claudia Djambas Khayat, et al.
Published: (2025-01-01) -
Probing rare von Willebrand disease–causing mutations in the D4 and C-domains of von Willebrand factor
by: Golzar Mobayen, et al.
Published: (2025-05-01) -
C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology
by: N V Seredavkina, et al.
Published: (2009-08-01) -
Atherosclerotic vessel damage in systemic lupus erythematosus and antiphospholipid syndrome in men
by: A. I. Iljina, et al.
Published: (2005-10-01)